Debate: Should the dose or duration of anticoagulants for the prevention of venous thrombosis be increased in patients with COVID-19 while we are awaiting the results of clinical trials?

Authors :: Gomez K
Laffan M
Bradbury C
Source :: British journal of haematology [Br J Haematol] 2021 Feb; Vol. 192 (3), pp. 459-466. Date of Electronic Publication: 2020 Nov 25.
Publication Year :: 2021

Subjects :: COVID-19 virology
Clinical Decision-Making
Clinical Trials as Topic
Disease Management
Disease Susceptibility
Duration of Therapy
Humans
Venous Thrombosis etiology
Anticoagulants administration & dosage
COVID-19 complications
SARS-CoV-2
Venous Thrombosis prevention & control

Full Text Access

Tools